Entry |
|
Name |
FLT3LG-FLT3-RAS-PI3K signaling pathway
|
Definition |
FLT3LG -> FLT3 -> GRB2 -> SOS -> RAS -> PI3K -> PIP3 -> AKT -> MTOR |
Expanded |
2323 -> 2322 -> 2885 -> (6654,6655) -> (3265,3845,4893) -> (5290,5291,5293) -> C05981 -> (207,208,10000) -> 2475 |
Class |
|
Type |
Reference
|
Pathway |
|
Gene |
2323 | FLT3LG; fms related tyrosine kinase 3 ligand |
2322 | FLT3; fms related tyrosine kinase 3 |
2885 | GRB2; growth factor receptor bound protein 2 |
6654 | SOS1; SOS Ras/Rac guanine nucleotide exchange factor 1 |
6655 | SOS2; SOS Ras/Rho guanine nucleotide exchange factor 2 |
3265 | HRAS; HRas proto-oncogene, GTPase |
3845 | KRAS; KRAS proto-oncogene, GTPase |
4893 | NRAS; NRAS proto-oncogene, GTPase |
5290 | PIK3CA; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha |
5291 | PIK3CB; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta |
5293 | PIK3CD; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta |
207 | AKT1; AKT serine/threonine kinase 1 |
208 | AKT2; AKT serine/threonine kinase 2 |
10000 | AKT3; AKT serine/threonine kinase 3 |
2475 | MTOR; mechanistic target of rapamycin |
|
Metabolite |
C05981 | Phosphatidylinositol-3,4,5-trisphosphate |
|
Reference |
|
Authors |
Gocek E, Studzinski GP |
Title |
The Potential of Vitamin D-Regulated Intracellular Signaling Pathways as Targets for Myeloid Leukemia Therapy. |
Journal |
|
Reference |
|
Authors |
Sun C, Bernards R |
Title |
Feedback and redundancy in receptor tyrosine kinase signaling: relevance to cancer therapies. |
Journal |
|
LinkDB |
|